{"id":27195,"date":"2026-11-10T05:47:09","date_gmt":"2026-11-10T05:47:09","guid":{"rendered":"https:\/\/thestrategystory.com\/blog\/?p=27195"},"modified":"2026-11-10T05:47:09","modified_gmt":"2026-11-10T05:47:09","slug":"wesfarmers-swot-analysis-in-2026","status":"publish","type":"post","link":"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/","title":{"rendered":"Wesfarmers SWOT Analysis in 2026: Strengths, Weaknesses, Opportunities and Threats"},"content":{"rendered":"<p>Wesfarmers SWOT Analysis in 2026 based on its official FY2026 Annual Report.<\/p>\n<h2>Strengths<\/h2>\n<h3>1. Large Bunnings franchise<\/h3>\n<p>Bunnings generated A$20.399 billion of segment revenue in FY2026.<\/p>\n<h3>2. Diverse customer markets<\/h3>\n<p>Retail, health, chemicals and industrial operations have different demand drivers.<\/p>\n<h3>3. Strong cash generation<\/h3>\n<p>FY2026 operating cash flow was A$4.272 billion.<\/p>\n<h3>4. Established value retail<\/h3>\n<p>Kmart Group generated A$11.751 billion of segment revenue.<\/p>\n<h3>5. Capital allocation flexibility<\/h3>\n<p>The group can reinvest, restructure or distribute cash across businesses.<\/p>\n<p>Related: <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-business-model-in-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-business-strategy-in-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/\">SWOT<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-pestel-analysis-in-2026\/\">PESTEL<\/a><\/p>\n<h2>Weaknesses<\/h2>\n<h3>1. Consumer spending exposure<\/h3>\n<p>Large retail operations depend on household budgets and demand.<\/p>\n<h3>2. Complex portfolio management<\/h3>\n<p>Businesses require different operating expertise and risk controls.<\/p>\n<h3>3. Rising financial debt<\/h3>\n<p>Net financial debt increased to A$5.295 billion.<\/p>\n<h3>4. Industrial and Safety revenue decline<\/h3>\n<p>Segment revenue fell to A$1.758 billion, partly reflecting portfolio changes.<\/p>\n<h3>5. Inventory and store costs<\/h3>\n<p>Retail operations face wages, rent, freight and markdown risks.<\/p>\n<p>Related: <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-business-model-in-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-business-strategy-in-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/\">SWOT<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-pestel-analysis-in-2026\/\">PESTEL<\/a><\/p>\n<h2>Opportunities<\/h2>\n<h3>1. Value-seeking consumers<\/h3>\n<p>Kmart&#8217;s affordability proposition may attract budget-conscious shoppers.<\/p>\n<h3>2. Home improvement demand<\/h3>\n<p>Renovation and trade customers support Bunnings opportunities.<\/p>\n<h3>3. Health distribution scale<\/h3>\n<p>Health revenue rose to A$6.474 billion.<\/p>\n<h3>4. Omnichannel efficiency<\/h3>\n<p>Better forecasting and fulfilment can improve customer experience.<\/p>\n<h3>5. Disciplined portfolio investment<\/h3>\n<p>Capital can be directed toward attractive risk-adjusted opportunities.<\/p>\n<p>Related: <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-business-model-in-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-business-strategy-in-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/\">SWOT<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-pestel-analysis-in-2026\/\">PESTEL<\/a><\/p>\n<h2>Threats<\/h2>\n<h3>1. Retail competition<\/h3>\n<p>Price pressure can reduce margins and traffic.<\/p>\n<h3>2. Consumer weakness<\/h3>\n<p>Inflation and interest costs may reduce discretionary purchases.<\/p>\n<h3>3. Supply-chain disruption<\/h3>\n<p>Shipping, sourcing and inventory interruptions affect availability.<\/p>\n<h3>4. Industrial volatility<\/h3>\n<p>Commodity and agricultural cycles influence chemicals and fertilisers.<\/p>\n<h3>5. Regulatory and cyber risk<\/h3>\n<p>Consumer, workplace, pharmacy and data obligations require strong controls.<\/p>\n<p>Related: <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-business-model-in-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-business-strategy-in-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/\">SWOT<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-pestel-analysis-in-2026\/\">PESTEL<\/a><\/p>\n<h3>Bunnings is a scale advantage, not a guarantee<\/h3>\n<p>Bunnings contributes a substantial share of group revenue, with A$20.399 billion in FY2026. Its trade and consumer customer relationships, product range and store network support its competitive position. However, housing activity and household budgets influence demand, while labour, freight and inventory costs affect profitability. Competitors can challenge prices and service. Investors should evaluate revenue growth alongside segment earnings and returns on capital. Scale is valuable when it produces efficient operations and dependable customer outcomes rather than merely a larger store footprint.<\/p>\n<h3>Why diversified businesses require separate analysis<\/h3>\n<p>Wesfarmers owns retailers, healthcare distribution and industrial operations. Their revenues respond differently to consumer spending, agricultural conditions, commodity prices and regulation. Diversification can reduce reliance on one market but also makes management more complex. A retail business may require inventory and leases, while a chemicals plant requires safety controls and significant fixed capital. Consolidated revenue alone cannot explain profitability. Investors should examine segment margins, capital employed and cash conversion before deciding whether the portfolio creates value.<\/p>\n<h3>Statutory earnings and significant items<\/h3>\n<p>Wesfarmers reported statutory FY2026 NPAT of A$2.874 billion, down 1.8%. However, FY2025 included significant items such as the Coregas sale gain. Excluding significant items, the prior-year NPAT was A$2.653 billion and FY2026 growth was 8.3%. Both comparisons are relevant. Statutory results capture actual accounting outcomes, while adjusted comparisons may clarify ongoing operations. Investors should not treat all excluded items as economically irrelevant. Asset disposals and portfolio changes can materially affect reported results and future cash generation.<\/p>\n<h3>Cash generation and debt<\/h3>\n<p>Operating cash flow declined to A$4.272 billion in FY2026, while net financial debt increased to A$5.295 billion. The company also reported free cash flow of A$3.992 billion under its definition. These measures should be analysed together with capital spending and shareholder distributions. Strong cash generation supports investment flexibility, but rising debt can increase exposure to financing costs. Retail inventory and industrial capital needs create additional demands on liquidity. Investors should distinguish cash returned to shareholders from cash available after maintaining and growing the business.<\/p>\n<h3>The opportunity in health<\/h3>\n<p>Wesfarmers Health generated A$6.474 billion of FY2026 revenue, up from A$5.933 billion. Pharmaceutical distribution and pharmacy retail serve essential needs and may diversify the group beyond discretionary shopping. Yet healthcare operations are regulated and can involve relatively low distribution margins, working capital requirements and complex supplier relationships. Revenue growth is not equivalent to earnings growth. The strategic opportunity lies in reliable service, operating efficiency and appropriate commercial expansion. Investors should assess profitability and capital returns rather than assume that healthcare demand alone guarantees success.<\/p>\n<h3>Risks in industrial and retail supply chains<\/h3>\n<p>Retail businesses depend on global sourcing, freight and inventory management. Industrial operations depend on reliable feedstocks, plant maintenance and safe processes. A supply disruption can reduce sales or increase costs, while excess inventory can tie up cash and require markdowns. Cyber incidents can affect payments and distribution systems. Wesfarmers&#8217; different divisions need tailored controls, although group-wide governance can support consistency. Operational resilience is important because customer trust and product availability influence long-term earnings.<\/p>\n<h3>Balanced SWOT assessment<\/h3>\n<p>Wesfarmers benefits from established retail franchises, diversified cash flows and capital allocation flexibility. Its weaknesses include portfolio complexity, retail operating costs and higher debt. Opportunities exist in value retail, health, technology and disciplined investment. Threats include weaker household demand, competition, supply disruption and regulation. These factors interact: a downturn can pressure sales while raising financing costs. This SWOT examines the business and is not a recommendation to buy or sell Wesfarmers shares. Valuation must be considered separately.<\/p>\n<p>Related: <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-business-model-in-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-business-strategy-in-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/\">SWOT<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-pestel-analysis-in-2026\/\">PESTEL<\/a><\/p>\n<p><h3>Bunnings and the housing cycle<\/h3>\n<p>Bunnings benefits from its extensive home improvement range and relationships with tradespeople, but housing activity and renovation budgets influence demand. Higher interest rates may constrain household spending, while maintenance and repair needs can persist through weaker cycles. The business must manage inventory, customer service and competitive pricing. Investors should monitor comparable sales and profitability rather than assume that Bunnings&#8217; market position protects it from economic fluctuations. Its scale is a strength only when supported by efficient operations and repeat customer relationships.<\/p>\n<h3>The trade-off in value retail<\/h3>\n<p>Kmart&#8217;s affordability proposition can attract consumers under financial pressure. Yet lower prices require disciplined sourcing, product development and inventory management to maintain margins. Supply-chain disruptions, quality problems or excessive markdowns can weaken the economics. Value retail may gain customer traffic during a downturn without automatically producing higher profits. The key is converting demand into cash and sustainable operating returns. This makes procurement capability and store productivity important competitive strengths.<\/p>\n<h3>Health as diversification with regulation<\/h3>\n<p>Wesfarmers Health provides exposure to pharmacy and pharmaceutical distribution, which differs from general merchandise retail. Medicine demand can be relatively resilient, but government policy, supplier terms and professional obligations shape economics. Distribution requires reliable inventory and logistics, while retail healthcare depends on customer trust. Segment revenue growth is encouraging, but investors should assess margins, capital employed and cash conversion. Healthcare scale does not guarantee high profitability if working capital and compliance costs are substantial.<\/p>\n<h3>Capital structure and financial flexibility<\/h3>\n<p>Net financial debt increased to A$5.295 billion in FY2026, while the group paid ordinary dividends and a separate capital management distribution. Debt can finance investment but also increases sensitivity to funding costs and downturns. Strong operating cash flow supports resilience, yet investors should consider leases, capital expenditure and the quality of earnings. Financial flexibility is particularly valuable for a diversified group because different divisions may need capital at different times.<\/p>\n<h3>Supply-chain exposure across divisions<\/h3>\n<p>The group&#8217;s scale creates purchasing opportunities but also dependence on reliable suppliers and logistics. Imported merchandise can be affected by freight disruption, exchange rates and trade policy. Chemicals and fertilisers require specialised feedstocks and safe plant operations. Pharmacy distribution depends on accurate handling and timely availability. These risks cannot be addressed by one uniform approach. Division-specific contingency planning and inventory controls are important. Investors should consider whether operating efficiency is achieved without excessive stock, weak supplier standards or avoidable service interruptions.<\/p>\n<h3>What the SWOT means for capital allocation<\/h3>\n<p>A diversified portfolio can absorb some business-specific shocks, but capital allocation determines whether diversification creates shareholder value. Management should prioritise investments where expected cash returns exceed the cost of capital after considering operational and regulatory risk. Bunnings, Kmart, Health and industrial operations have different economics, so revenue growth should not be the sole investment criterion. Debt, dividends and acquisitions compete for resources. Investors should compare segment performance, cash conversion and balance-sheet flexibility over time. A strong brand or large market share is valuable only when it supports durable risk-adjusted returns.<\/p>\n<p><strong>Source:<\/strong> <a href=\"https:\/\/www.wesfarmers.com.au\/investor-centre\/company-performance-news\/results-presentations\">Wesfarmers Annual Report 2026<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wesfarmers SWOT analysis in 2026: Bunnings, Kmart, Health, consumer spending, supply chains, competition and regulation.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[111],"tags":[],"class_list":{"0":"post-27195","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-swot-analysis"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Wesfarmers SWOT Analysis in 2026: Strengths, Weaknesses, Opportunities and Threats - The Strategy Story<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wesfarmers SWOT Analysis in 2026: Strengths, Weaknesses, Opportunities and Threats - The Strategy Story\" \/>\n<meta property=\"og:description\" content=\"Wesfarmers SWOT analysis in 2026: Bunnings, Kmart, Health, consumer spending, supply chains, competition and regulation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"The Strategy Story\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-10T05:47:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/03\/TSS-logo-11-modified.png\" \/>\n\t<meta property=\"og:image:width\" content=\"403\" \/>\n\t<meta property=\"og:image:height\" content=\"403\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shikhar Goel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shikhar Goel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/\",\"url\":\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/\",\"name\":\"Wesfarmers SWOT Analysis in 2026: Strengths, Weaknesses, Opportunities and Threats - The Strategy Story\",\"isPartOf\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\"},\"datePublished\":\"2026-11-10T05:47:09+00:00\",\"dateModified\":\"2026-11-10T05:47:09+00:00\",\"author\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071\"},\"breadcrumb\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thestrategystory.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wesfarmers SWOT Analysis in 2026: Strengths, Weaknesses, Opportunities and Threats\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\",\"url\":\"https:\/\/thestrategystory.com\/blog\/\",\"name\":\"The Strategy Story\",\"description\":\"Simplifying Business Strategies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071\",\"name\":\"Shikhar Goel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g\",\"caption\":\"Shikhar Goel\"},\"url\":\"https:\/\/thestrategystory.com\/blog\/author\/tss-publisher\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wesfarmers SWOT Analysis in 2026: Strengths, Weaknesses, Opportunities and Threats - The Strategy Story","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/","og_locale":"en_US","og_type":"article","og_title":"Wesfarmers SWOT Analysis in 2026: Strengths, Weaknesses, Opportunities and Threats - The Strategy Story","og_description":"Wesfarmers SWOT analysis in 2026: Bunnings, Kmart, Health, consumer spending, supply chains, competition and regulation.","og_url":"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/","og_site_name":"The Strategy Story","article_published_time":"2026-11-10T05:47:09+00:00","og_image":[{"width":403,"height":403,"url":"https:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/03\/TSS-logo-11-modified.png","type":"image\/png"}],"author":"Shikhar Goel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Shikhar Goel","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/","url":"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/","name":"Wesfarmers SWOT Analysis in 2026: Strengths, Weaknesses, Opportunities and Threats - The Strategy Story","isPartOf":{"@id":"https:\/\/thestrategystory.com\/blog\/#website"},"datePublished":"2026-11-10T05:47:09+00:00","dateModified":"2026-11-10T05:47:09+00:00","author":{"@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071"},"breadcrumb":{"@id":"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/thestrategystory.com\/blog\/wesfarmers-swot-analysis-in-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thestrategystory.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Wesfarmers SWOT Analysis in 2026: Strengths, Weaknesses, Opportunities and Threats"}]},{"@type":"WebSite","@id":"https:\/\/thestrategystory.com\/blog\/#website","url":"https:\/\/thestrategystory.com\/blog\/","name":"The Strategy Story","description":"Simplifying Business Strategies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071","name":"Shikhar Goel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g","caption":"Shikhar Goel"},"url":"https:\/\/thestrategystory.com\/blog\/author\/tss-publisher\/"}]}},"_links":{"self":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/comments?post=27195"}],"version-history":[{"count":2,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27195\/revisions"}],"predecessor-version":[{"id":27202,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27195\/revisions\/27202"}],"wp:attachment":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/media?parent=27195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/categories?post=27195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/tags?post=27195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}